EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Are Δ9-Tetrahydrocannabinol and Its Major Metabolites Substrates or Inhibitors of Placental or Human Hepatic Drug Solute-Carrier Transporters?

Xin Chen iD, Zsuzsanna Gáborik, Qingcheng Mao, Jashvant D Unadkat iD

International Journal of Molecular Sciences · 2024

DOI: 10.3390/ijms252212036 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2024. Verfasst von Xin Chen und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmaceutics, School of Pharmacy, University of Washington, Seattle, WA 98195, USA. Hauptthemen laut MEDLINE: Dronabinol, Placenta, Liver. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 28 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIDA NIH HHS, National Institute on Drug Abuse.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Δ9-Tetrahydrocannabinol (THC) is the primary psychoactive component of cannabis which is being increasingly consumed by pregnant people. In humans, THC is sequentially metabolized in the liver to its circulating metabolites 11-hydroxy-THC (11-OH-THC, psychoactive) and 11-nor-9-carboxy-THC (THC-COOH, non-psychoactive). Human and macaque data show that fetal exposure to THC is considerably lower than the corresponding maternal exposure. Through perfused human placenta studies, we showed that this is due to the active efflux of THC (fetal-to-maternal) by a placental transporter(s) other than P-glycoprotein or breast cancer resistance protein. The identity of this placental transporter(s) as well as whether THC or its metabolites are substrates or inhibitors of hepatic solute carrier transporters is unknown. Therefore, we investigated whether 5 μM THC, 0.3 μM 11-OH-THC, and 2.5 μM THC-COOH are substrates and/or inhibitors of placental or hepatic solute carrier transporters at their pharmacologically relevant concentrations. Using HEK cells overexpressing human OATP1B1, OATP1B3, OATP2B1, OCT1, OCT3, OAT2, OAT4, or NTCP, and prototypic substrates/inhibitors of these transporters, we found that THC and THC-COOH were substrates but not inhibitors of OCT1. THC-COOH was a weak substrate of OCT3 and a weak inhibitor of OAT4. THC, 11-OH-THC, and THC-COOH were found not to be substrates/inhibitors of the remaining transporters investigated.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

DronabinolPlacentaLiverHumansFemalePregnancySolute Carrier ProteinsBiological TransportHEK293 Cells

Stichwörter der Autor:innen

THCliverplacentapregnancysolute carriertransporters

Substanzen

DronabinolSolute Carrier Proteins

Autor:innen und Institutionen

  • Department of Pharmaceutics, School of Pharmacy, University of Washington, Seattle, WA 98195, USA.
  • SOLVO Biotechnology, Charles River Laboratories Hungary, Irinyi József u. 4-20, 1117 Budapest, Hungary.

ORCID-Profile: Xin Chen, Jashvant D Unadkat

Förderung

  • NIDA NIH HHS
  • National Institute on Drug Abuse

Zitieren

APA

Chen, X., Gáborik, Z., Mao, Q., & Unadkat, J. D. (2024). Are Δ9-Tetrahydrocannabinol and Its Major Metabolites Substrates or Inhibitors of Placental or Human Hepatic Drug Solute-Carrier Transporters?. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms252212036

Vancouver

Chen X, Gáborik Z, Mao Q, Unadkat JD. Are Δ9-Tetrahydrocannabinol and Its Major Metabolites Substrates or Inhibitors of Placental or Human Hepatic Drug Solute-Carrier Transporters?. International Journal of Molecular Sciences. 2024. doi:10.3390/ijms252212036

BibTeX
@article{Chen2024,
  author = {Chen, Xin and Gáborik, Zsuzsanna and Mao, Qingcheng and Unadkat, Jashvant D},
  title = {Are Δ9-Tetrahydrocannabinol and Its Major Metabolites Substrates or Inhibitors of Placental or Human Hepatic Drug Solute-Carrier Transporters?},
  journal = {International Journal of Molecular Sciences},
  year = {2024},
  doi = {10.3390/ijms252212036}
}
Kostenlos starten →